Effects of illicit dexamethasone upon hepatic drug metabolizing enzymes and related transcription factors mRNAs and their potential use as biomarkers in cattle

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 2, 2010, Pages 1342-1349

  Giantin, Mery ^a   Lopparelli, Rosa M ^a   Zancanella, Vanessa ^a   Martin, Pascal G ^b   Polizzi, Arnaud ^b   Gallina, Guglielmo ^a   Gottardo, Flaviana ^a   Montesissa, Clara ^a   Ravarotto, Licia ^c   Pineau, Thierry ^b   Dacasto, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CEMAGREF   (France)

^c ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

Biomarker; Cattle; Dexamethasone; Drug metabolizing enzymes; Gene expression; Growth promoters

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450; DEXAMETHASONE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; CATTLE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; EVALUATION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIVER; MALE; METABOLISM; METHODOLOGY; SUBSTANCE ABUSE;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; LIVER; MALE; RNA, MESSENGER; SUBSTANCE ABUSE DETECTION; TRANSCRIPTION FACTORS;

ANIMALIA; BOS;

EID: 74849138959     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9033317     Document Type: Article

References (55)

1. Courtheyn, D.; Le Bizec, B.; Brambilla, G.; De Brabander, H. F.; Cobbaert, E.; Van de Wiele, M.; Vercammen, J.; De Wasch, K. Recent developments in the use and abuse of growth promoters. Anal. Chim. Acta 2002, 473, 71-82.
2. Serratosa, J.; Blass, A.; Rigau, B.; Mongrell, B.; Rigau, T.; Tortadés, M.; Tolosa, E.; Aguilar, C.; Ribó, O.; Balagué, J. Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European perspective. Rev. Sci. Tech. Off. Int. Epiz. 2006, 25, 637-653.
3. Vincenti, M.; Girolami, F.; Capra, P.; Pazzi, M.; Carletti, M.; Gardini, G.; Nebbia, C. Study of dexamethasone urinary excretion profile in cattle by LC-MS/MS: comparison between therapeutic and growth-promoting administration. J. Agric. Food Chem. 2009, 57, 1299-1306.
4. Toffolatti, L.; Gastaldo, R. L.; Patarnello, T.; Romualdi, C.; Merlanti, R.; Montesissa, C.; Poppi, L.; Castagnaro, M.; Bargelloni, L. Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest. Anim. Endocrinol. 2006, 30, 39-55.
5. Reiter, M.; Walf, V. M.; Christians, A.; Pfaffl, M. W.; Meyer, H. H. Modifications of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers. Anal. Chim. Acta 2007, 586, 73-81.
6. Carraro, L.; Ferraresso, S.; Cardazzo, B.; Romualdi, C.; Montesissa, C.; Gottardo, F.; Patarnello, T.; Castagnaro, M.; Bargelloni, L. Expression profiling of skeletal muscle in young bulls treated with steroidal growth promoters. Physiol. Genomics 2009, 38, 138-148.
7. De Maria, R.; Divari, S.; Goria, M.; Bollo, E.; Cannizzo, F. T.; Olivero, M.; Barbarino, G.; Biolatti, B. 17β-Estradiol-induced gene expression in prostate cell culture and tissue from cattle: biomarkers to detect illegal use of growth promoters. Vet. Rec. 2009, 164, 459-464.
8. Riedmaier, I.; Tichopad, A.; Reiter, M.; Pfaffl, M. W.; Meyer, H. H. D. Identification of potential gene expression biomarkers for the surveillance of anabolic agents in bovine blood cells. Anal. Chim. Acta 2009, 638, 106-113.
9. Xu, C.; Li, C. Y.; Kong, A. N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28, 249-268.
10. Ioannides, C. Cytochrome P450 expression in the liver of foodproducing animals. Curr. Drug Metab. 2006, 7, 335-348.
11. Fink-Gremmels, J. Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. Eur. J. Pharmacol. 2008, 585, 502-509.
12. Greger, D. L.; Philipona, C.; Blum, J. W. Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domest. Anim. Endocrinol. 2006, 31, 76-87.
13. Greger, D. L.; Blum, J. W. Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calves. J. Anim. Physiol. Anim. Nutr. (Berl.) 2007, 91, 62-67.
14. Giantin, M.; Carletti, M.; Capolongo, F.; Pegolo, S.; Lopparelli, R. M.; Gusson, F.; Nebbia, C.; Cantiello, M.; Martin, P.; Pineau, T.; Dacasto, M. Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver. Drug Metab. Dispos. 2008, 36, 885-893.
15. Al Katheeri, N. A.; Wasfi, I. A.; Lambert, M.; Giuliano Albo, A.; Nebbia, C. In vitro and in vivo metabolism of dexamethasone in the camel. Vet. J. 2006, 172, 532-543.
16. Pascussi, J. M.; Gerbal-Chaloin, S.; Drocourt, L.; Maurel, P.; Vilarem, M. J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle network of nuclear and steroid receptors. Biochim. Biophys. Acta 2003, 1619, 243-253.
17. Cantiello, M.; Carletti, M.; Dacasto, M.; Martin, P. G. P.; Pineau, T.; Capolongo, F.; Gardini, G.; Nebbia, C. Cytochrome P450 inhibition profile in liver of veal calves administered a combination of 17β-oestradiol, clenbuterol, and dexamethasone for growth-promoting purposes. Food Chem. Toxicol. 2008, 46, 2849-2855.
18. Cantiello, M.; Giantin, M.; Carletti, M.; Lopparelli, R. M.; Capolongo, F.; Lasserre, F.; Bollo, E.; Martin, P. G.; Nebbia, C.; Pineau, T.; Dacasto, M. Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression in veal calf. Biochem. Pharmacol. 2009, 77, 451-463.
19. Cannizzo, F. T.; Miniscalco, B.; Riondato, F.; Bollo, E.; Barbarino, G.; Giorgi, P.; Mazzini, C.; Biolatti, B. Effects of anabolic and therapeutic doses of dexamethasone on thymus morphology and apoptosis in veal calves. Vet. Rec. 2008, 163, 448-452.
20. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001, 25, 402-408. (Pubitemid 34164012)
21. Luo, G.; Guenthner, T.; Gan, L.-S.; Griffith Humphreys, W. CYP3A induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr. Drug Metab. 2004, 5, 483-505.
22. Tomlinson, E. S.;Maggs, J.L.; Park,B.K.; Back,D. J.Dexamethasone metabolismin vitro: species differences. J. Steroid Biochem.Molec.Biol. 1997, 62, 345-352.
23. Pascussi, J.-M.; Drocourt, L.; Gerbal-Chaloin, S.; Fabre, J.-M.; Maurel, P.; Vilarem, M.-J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur. J. Biochem. 2001, 268, 6346-6358.
24. Ribarac-Stepić, N.; Vulović, M.; Korićanac, G.; Isenović, E. Basal and glucorticoid induced changes of hepatic glucorticoid receptor during aging: relation to activities of tyrosine aminotransferase and tryptophan oxygenase. Biogerontology 2005, 6, 113-131.
25. Duret, C.; Daujat-Chavanieu, M.; Pascussi, J.-M.; Pichard-Garcia, L.; Balaguer, P.; Fabre, J.-M.; Vilarem, M. J.; Maurel, P.; Gerbal-Chaloin, S. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol. Pharmacol. 2006, 70, 329-339.
26. Dvořák, Z.; Modrianský, M.; Pichard-Garcia, L.; Balaguer, P.; Vilarem, M.-J.; Ulrichova, J.; Maurel, P.; Pascussi, J.-M. Colchicine down-regulates cytochrome P450 2B6, 2C9, and CYP3A4 in human hepatocytes by affecting their glucorticoid receptor-mediated regulation. Mol. Pharmacol. 2003, 64, 160-169
27. Pascussi, J. M.; Gerbal-Chaloin, S.; Fabre, J. M.; Maurel, P.; Vilarem, M. J. Dexamethasone enhances androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol. Pharmacol. 2000, 58, 1441-1450.
28. Cui, X.; Thomas, A.; Han, Y.; Palamanda, J.; Montgomery, D.; White, R. E.; Morrison, R. A.; Cheng, K. C. Quantitative PCR assay for cytochrome P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo. J. Pharmacol. Toxicol. Methods 2005, 52, 234-243.
29. Lee, C. M.; Kim, B. Y.; Li, L.; Morgan, E. T. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J. Biol. Chem. 2008, 283, 889-898.
30. Cederbaum, A. I. CYP2E1 - Biochemical and toxicological aspects and role in alcohol-induced liver injury. Mt. Sinai J. Med. 2006, 73, 657-672.
31. Tambyrajah, W. S.; Doran, E.; Wood, J. D.; McGivan, J. D. The pig CYP2E1 promoter is activated by COUP-TF1 and HNF-1 and is inhibited by androsterone. Arch. Biochem. Biophys. 2004, 431, 252-260.
32. Zamaratskaia, G.; Gilmore, W. J.; Lundström, K.; Squires, E. J. Effect of testicular steroids on catalytic activities of cytochrome P450 enzymes in porcine liver microsomes. Food Chem. Toxicol. 2007, 45, 676-681.
33. Yao, H.-T.; Lin, P.; Chang, Y.-W.; Chen, C.-T.; Chiang, M.-T.; Chang, L.; Kuo, Y.-C.; Tsai, H.-T.; Yeh, T.-K. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Food Chem. Toxicol. 2009, 47, 1703-1709.
34. Abdelmegeed, M. A.; Carruthers, N. J.; Woodcroft, K. J.; Kim, S. K.; Novak, R. F. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 2005, 315, 203-213.
35. Zweers-Zeilmaker, W. M.; Maas, R. F. M.; Horbach, G. J.; Van Miert, A. S. J. P. A. M.; Witkamp, R. F. Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate. J. Vet. Pharmacol. Ther. 1996, 19, 245-250.
36. Maciel, S. M.; Chamberlain, C. S.; Wetterman, R. P.; Spicer, L. J. Dexamethasone influences endocrine and ovarian function in cattle. J. Dairy Sci. 2001, 84, 1998-2008.
37. Badawi, A. F.; Cavalieri, E. L.; Rogan, E. G. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16α-hydroxylation of 17β-estradiol. Metabolism 2001, 9, 1001-1003. (Pubitemid 32904154)
38. Nishimura, M.; Koeda, A.; Suganuma, Y.; Suzuki, E.; Shimizu, T.; Nakayama, M.; Satoh, T.; Narimatsu, S.; Naito, S. Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab. Pharmacokinet. 2007, 22, 178-186.
39. Navas, J. M.; Segner, H. Estrogen-mediated suppression of cytochrome P4501A1 (CYP1A) expression in rainbow trout hepatocytes: role of estrogen receptor. Chem. Biol. Interact. 2001, 138, 285-298.
40. Son, D. S.; Roby, K. F.; Rozman, K. K.; Terranova, P. F. Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Toxicology 2002, 176, 229-243.
41. Cuzzocrea, S.; Bruscoli, S.; Crisafulli, C.; Mazzon, E.; Agostani, M.; Muia, C.; Esposito, E.; Di Virgilio, R.; Meli, R.; Vegeto, E.; Maggi, A.; Riccardi, C. Estrogen receptor antagonist fulvestrant (ICI 182,780) inhibits the anti-inflammatory effects of glucocorticoids. Mol. Pharmacol. 2007, 71, 132-144.
42. Duamnu, Z.; Kocarek, T. A.; Runge-Morris, M. Transcriptional regulation of rat hepatic aryl sulphotransferase (SULT1A1) gene expression by glucocorticoids. Drug Metab. Dispos. 2001, 29, 1130-1135.
43. Schauss, S. J.; Henry, T.; Palmatier, R.; Halvorson, L.; Dannenbring, R.; Beckmann, J. D. Characterization of bovine tracheobronchial phenol sulphotransferase cDNA and detection of mRNA regulation by cortisol. Biochem. J. 1995, 311, 209-217.
44. Nebbia, C.; Dacasto, M; Rossetto Giaccherino, A.; Giuliano Albo, A.; Carletti, M. Comparative expression of liver cytochrome P450dependent monooxygenases in the horse and in other agricultural and laboratory species. Vet. J. 2003, 165, 53-64. (Pubitemid 38001823)
45. Szotáková, B.; Baliharová, V.; Lamka, J.; Nožinová, E.; Wsól, V.; Velík, J.; Machala, M.; Neča, J.; Souček, P.; Šusová, S.; Skálová, L. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res. Vet. Sci. 2004, 76, 43-51.
46. Skaanild, M. Porcine cytochrome P450 and metabolism. Curr. Pharm. Res. 2006, 12, 1421-1427.
47. Tydén, E.; Olsén, L.; Tallkvist, J.; Tjälve, H.; Larsson, P. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse. Res. Vet. Sci. 2008, 85, 80-85.
48. Gardini, G.; Del Boccio, P.; Colombatto, S.; Testore, G.; Corpillo, D.; Di Ilio, C.; Urbani, A.; Nebbia, C. Proteomic investigation in the detection of illicit treatment of calves with growth-promoting agents. Proteomics 2006, 6, 2813-2822. (Pubitemid 43752041)
49. Draisci, R.; Montesissa, C.; Santamaria, B.; D'Ambrosio, C.; Ferretti, G.; Merlanti, R.; Ferranti, C.; De Liguoro, M.; Cartoni, C.; Pistarino, E.; Ferrara, L.; Tiso, M.; Scaloni, A.; Cosulich, M. E. Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: urine and plasma kinetic profile and changes in plasma protein expression. Proteomics 2007, 7, 3184-3193.
50. Nebbia, C.; Della Donna, L.; Carletti, M.; Balbo, A.; Barbarino, G.; Gardini, G. Use of hepatic protein biomarkers for tracing the exposure of veal calves to illegal growth promoters: investigations on experimental samples and preliminary application under field conditions. J. Vet. Pharmacol. Ther. 2008, 31, 272-275.
51. Vels, L.; Roentved, C. M.; Bjerring, M.; Ingvartsen, K. L. Cytokine and acute phase protein gene expression in repeated liver biopsies of dairy cows with a lipopolysaccharide-induced mastitis. J. Dairy Sci. 2009, 92, 922-934.
52. Mohr, S.; Liew, C.-C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol. Med. 2007, 13, 422-432.
53. Liptrott, N. J.; Penny, M.; Bray, P. G.; Sathish, J.; Khoo, S. H.; Back, D. J.; Owen, A. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. 2009, 156, 497-508.
54. Wang, A.-H.; Zhu, S.-M.; Qiu, Y.-L.; Zhu, R.; Qu, Y.-B.; Li, Y.-L.; Brandt-Rauf, P. W.; Xia, Z.-L. CYP2E1 mRNA expression, genetic polymorphism in peripheral blood lymphocytes and liver abnormalities in chines VCM-exposed workers. Int. J. Occup. Med. Env. 2008, 21, 141-146.
55. Timbrell, J. A. Biomarkers in toxicology. Toxicology 1998, 129, 1-12.